ATRC analyst estimates
AtriCure (ATRC) analyst ratings, the average price target and its range, and every firm's latest call.
ATRC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 17, 2026 | Stifel Nicolaus | AtriCure Inc. (ATRC) PT Raised to $65 by Stifel - Physicians Favor LAAM Technology | $65.00 |
| Sep 2, 2026 | Needham | AtriCure Inc. (ATRC) PT Raised to $64 at Needham | $64.00 |
| Aug 27, 2026 | Piper Sandler | AtriCure price target raised to $60 from $50 at Piper Sandler | $60.00 |
| Aug 24, 2026 | BTIG | AtriCure Inc. (ATRC) PT Raised to $55 at BTIG | $55.00 |
| Jul 28, 2026 | UBS | AtriCure price target lowered to $50 from $55 at UBS | $50.00 |
| Jul 21, 2026 | Raymond James | AtriCure (ATRC) Reiterated at Market Outperform by Citizens on Consistent Product Iteration | $52.00 |
| May 6, 2026 | Canaccord Genuity | AtriCure price target raised to $55 from $53 at Canaccord | $55.00 |
| Feb 18, 2026 | Oppenheimer | AtriCure downgraded to Perform from Outperform at Oppenheimer | $44.00 |
| Feb 18, 2026 | Canaccord Genuity | AtriCure price target lowered to $53 from $64 at Canaccord | $53.00 |
| Feb 18, 2026 | UBS | AtriCure price target lowered to $55 from $60 at UBS | $55.00 |
| Oct 30, 2025 | Canaccord Genuity | AtriCure Inc. (ATRC) PT Raised to $64 at Canaccord Genuity | $64.00 |
| Jul 30, 2025 | BTIG | AtriCure price target raised to $54 from $52 at BTIG | $54.00 |
| Jul 31, 2024 | BTIG | AtriCure Inc. (ATRC) PT Lowered to $53 at BTIG | $53.00 |
| Jul 31, 2024 | Piper Sandler | AtriCure price target lowered to $40 from $65 at Piper Sandler | $40.00 |
| Jul 31, 2024 | Stifel Nicolaus | AtriCure price target lowered to $26 from $30 at Stifel | $26.00 |
- 9 firms rate ATRC: 7 buy, 2 hold, 0 sell.
- The average price target is $57.29 from 7 analysts, from $50.00 to $65.00.
Updated 2026-11-03 00:00 UTC